Мобильная версия

Доступно журналов:

3 288

Доступно статей:

3 891 637

 

Скрыть метаданые

Автор Maricq, Hildegard, R
Автор Valter, Ivo
Автор Maricq, John, G
Дата выпуска 1998
dc.description The treatment efficacy of patients with Raynaud phenomenon (RP) is determined from the decrease in severity of this condition, usually based on a decrease in frequency of RP attacks as reported by patients in a diary. Although subjective, this method is still the main endpoint measure in clinical trials.The results of patients' digital blood pressure responses to cooling were compared with the reported RP attack frequency to determine whether the former could be used to estimate the severity of RP. The effect of local finger cooling on the digital systolic blood pressure was tested at 30°C, 20°C, 15°C and 10°C on 136 subjects with RP. The RP attack frequency was dichotomized into daily versus less than daily attacks.The frequency of attacks and the digital systolic pressure (DSP) showed a significant association at all cooling temperatures (those with daily attacks showed lower DSP than those with less frequent attacks). In addition, patients experiencing daily attacks of RP showed a zero reopening pressure at higher local temperatures than those with less frequent RP attacks.These results demonstrate that the response of the digital systolic blood pressure to cooling is closely associated with the RP attack frequency and therefore can be considered as an objective estimate of RP severity. This physiological measurement should be most useful in evaluating the clinical course of RP and the effect of its treatment, provided it is measured under standardized conditions.
Издатель Sage Publications
Тема attack frequency
Тема digital blood pressure
Тема Raynaud phenomenon
Название An objective method to estimate the severity of Raynaud phenomenon: digital blood pressure response to cooling
Тип Journal Article
DOI 10.1177/1358836X9800300204
Print ISSN 1358-836X
Журнал Vascular Medicine
Том 3
Первая страница 109
Последняя страница 113
Аффилиация Maricq, Hildegard, R, Department of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USA
Аффилиация Valter, Ivo, Department of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USA
Аффилиация Maricq, John, G, Department of Medicine, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USA
Выпуск 2
Библиографическая ссылка Maricq HR, Weinrich MC, Valter I, Palesch YY, Maricq JG.Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud’s phenomenon, or scleroderma spectrum disorders. J Rheumatol1996; 23: 2068-2078.
Библиографическая ссылка Belch JJF, Shaw B, Sturrock RD, Madhok R, Leiberman P, Forbes CD.Double-blind trial of CL115,347, a transdermally absorbed prostaglandin E2 analogue, in treatment of Raynaud’s phenomenon. Lancet1985; i: 1180-1183.
Библиографическая ссылка Nilsson H, Jonasson T, Leppert J, Ringquist I.The effect of the calcium-entry blocker nifedipine on cold-induced digital vasospasm. Acta Med Scand1987; 221: 53-60.
Библиографическая ссылка Weber A, Bounameaux H.Effects of low-dose nifedipine on a cold provocation test in patients with Raynaud’s disease. J Cardiovasc Pharmacol1990; 15: 853-855.
Библиографическая ссылка Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum1980; 23: 581-590.
Библиографическая ссылка Maricq HR, Weinrich MC, Keil JEet al.Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum1989; 32: 998-1006.
Библиографическая ссылка Maricq HR, Carpentier PH, Weinrich MCet al.Geographic variation in the prevalence of Raynaud’s phenomenon: a 5 region comparison. J Rheumatol1997; 24: 879-889.
Библиографическая ссылка Nielsen SL, Vitting K, Rasmussen K.Prazosin treatment of primary Raynaud’s phenomenon. Eur J Clin Pharmacol1983; 24: 421-423.
Библиографическая ссылка Rodeheffer RJ, Rommer JA, Wigley F, Smith CR.Controlled double-blind trial of nifedipine in the treatment of Raynaud’s phenomenon. N Engl J Med1983; 308: 880-883.
Библиографическая ссылка Ettinger WH, Wise RA, Schaffhauser D, Wigley FM.Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud’s phenomenon. Am J Med1984; 77: 451-458.
Библиографическая ссылка Nilsson H, Jonasson T, Ringquist I.Treatment of digital vasospastic disease with the calcium-entry blocker nifedipine. Acta Med Scand1984; 215: 135-139.
Библиографическая ссылка Nielsen SL.Raynaud phenomena and finger systolic pressure during cooling. Scand J Clin Lab Invest1978; 38: 765-770.
Библиографическая ссылка Hoare M, Miles C, Girvan Ret al.The effect of local cooling on digital systolic pressure in patients with Raynaud’s syndrome. Br J Surg1982; 69 (suppl): S27-S28.
Библиографическая ссылка Carter SA, Dean E, Kroeger EA.Apparent finger systolic pressures during cooling in patients with Raynaud’s syndrome. Circulation1988; 77: 988-996.

Скрыть метаданые